
Enovis Corp (ENOV) Stock Forecast & Price Target
Enovis Corp (ENOV) Analyst Ratings
Bulls say
Enovis is expected to see steady growth and increasing operational leverage in the future, strengthened by its multi-segmented approach and new product launches. Its exposure to the bone growth stimulation market may be limited, resulting in minimal impact from potential reimbursement reductions. While there are risks such as tariff exposure and competition, overall, Enovis has a strong financial position and potential for future growth.
Bears say
Enovis is currently facing several challenges that may hinder its growth in the near term, including potential pricing pressure and market share erosion as new competitors enter the market with the company's reclassified products. Additionally, the company's strong reliance on its older Prevention & Recovery segment may limit its growth potential and result in slower-than-expected top-line growth. These challenges, combined with the potential for continued tariff pressures and unsuccessful M&A integration, contribute to our negative outlook on Enovis's stock.
This aggregate rating is based on analysts' research of Enovis Corp and is not a guaranteed prediction by Public.com or investment advice.
Enovis Corp (ENOV) Analyst Forecast & Price Prediction
Start investing in Enovis Corp (ENOV)
Order type
Buy in
Order amount
Est. shares
0 shares